中牧股份(600195.SH):已有9549人簽訂布魯氏菌抗體陽性事件補償賠償協議 涉及金額約7185萬元
格隆匯 1 月 12日丨中牧股份(600195.SH)公佈,公司持續跟進蘭州布魯氏菌抗體陽性事件進展情況。
中牧實業股份有限公司蘭州生物藥廠(“蘭州廠”)積極做好補償賠償人員的協議簽訂及資金支付工作,截至1月8日,經甘肅省疾控中心複核確認的布魯氏菌抗體陽性人員11310人,其中已有9549人簽訂補償賠償協議,涉及金額約7185萬元。
按照省市相關政府部門對布魯氏菌抗體陽性事件善後處置工作“應檢盡檢、願檢盡檢”的指導原則,檢測範圍擴大到鹽場路街道從業人員和暫住人員,及特定時間段在鹽場路街道區域短暫從業或者居住過的人員。同時依據2020年11月28日新修訂的補償賠償協議,對2020年7月17日後抗體試管凝集試驗滴度1:50++及以上、1:100++以下的布魯氏菌抗體陽性人員進行再次確認,因此經省級複核確認的布魯氏菌抗體陽性人數有所增加。
蘭州廠將繼續積極配合省市相關政府部門做好善後處置和補償賠償工作,安排工作人員在蘭州市鹽場路的布魯氏菌抗體陽性事件善後工作處做好協議簽訂工作。公司將通過督促蘭州廠按時足額落實補償賠償資金,保障補償金額及時支付,切實維護羣眾的健康權益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.